fda bans semaglutide U.S. finds no evidence yet linking weight-loss drugs to suicidal thoughts Oral Semaglutide Gets FDA Approval
Description
Participants : Over 1,600 adults with obesity or overweight and type 2 diabetes

Adding New Medications (in low doses) to Proven Center for Nutrition Protocols is a Strategy for Success

The company has now added compounded GLP-1 injections with the same active ingredient as buzzy branded weight loss drugs Ozempic and Wegovy, executives said

Matsui, T

A similar pattern emerged during my GLP-1 washout in October 2025

Products are sold online with minimal oversight, often labeled as "research chemicals" or "not for human consumption" to skirt regulatory requirements while clearly being marketed for human use
